FDA Finalizes Guidance On ‘Unique Challenges’ Of Psychedelic Research And Schedules Hearing On Therapeutic Uses
June 13, 2023 Accessibility To Medical Cannabis In Israel To Be Made Easier For Some Until now, to get medical cannabis legally, a patient had to obtain a license with the approval of the ministry or certain doctors
June 9, 2023 Expedite Research On Medicinal Usage Of Cannabis: Jitendra Singh Singh stressed that a synergy between the country’s premier institutions
June 9, 2023 Study: Cannabis Use Associated with Sustained Benefits in Patients with Gilles de la Tourette Syndrome “Patients using medical cannabis reported an average 75 percent tic reduction compared with baseline,” investigators determined.
May 31, 2023 Cannabis Can Be A Game-Changer For Improving The Lives Of Autistic Adults Researchers have found that medicinal cannabis could be a promising treatment for adults with autism spectrum disorder
May 30, 2023 Cannabis and Women’s Health: Empowering Discussions on Wellness and Well-Being Various discussions about different sorts of marijuana and its benefits for women’s health have gained significant attention recently.
May 29, 2023 Study Results Prompt Call For Medicinal Cannabis Policy Evaluation A New Zealand study into the therapeutic benefits of cannabis has added to the growing body of evidence that it has positive effects
May 23, 2023 Cannabis And Migraines: Here’s What The Research Tells Us Do cannabinoids aid in migraines, and which types of migraines have been studied? Let’s take a look at existing data on migraines and cannabinoids.
May 16, 2023 How Medical Cannabis Can Improve Your Quality of Life if You Have Chronic Pain Many people with cancer-related pain, chronic pain, or other health conditions turn to medical cannabis to relieve their symptoms.
May 10, 2023 Medical Cannabis Improves Quality of Life in People With Chronic Pain, Other Conditions Many people with cancer-related pain, chronic pain, or other health conditions turn to medical cannabis to relieve their symptoms.
Medical May 7, 2023 Phase 2 Psilocybin Therapy Trial For Patients With Treatment-Resistant PTSD: Latest Findings Cannabis company Creso Pharma COPHF’s wholly-owned psychedelics subsidiary Halucenex Life Sciences Inc. shared promising early findings